PPT-Decentralized Trials: Regulatory and Implementation Issues

Author : jaena | Published Date : 2024-02-02

C Karen Jeans PhD CCRN CIP VHA Office of Research and Development ORD 2023 IRB and Research amp Development RampD Committee Chairs Workshop February 79 2023 Objectives

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Decentralized Trials: Regulatory and Im..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Decentralized Trials: Regulatory and Implementation Issues: Transcript

C Karen Jeans PhD CCRN CIP VHA Office of Research and Development ORD 2023 IRB and Research amp Development RampD Committee Chairs Workshop February 79 2023 Objectives Define the term decentralized trials. The racing regulatory veterinarians reiterated their concern that the permissive nonsteroidal antiinflammatory NSAID policies in the United States are compromising the examining veterinarians ability to indentify horses at risk for catastrophic inju Data . Communications. Implementation . Team (DCIT. ). DCIT . #31 . PLENARY. DCL Trials Update. 3/13/2014. Matt Maki. DCL Trials Lead. DTAP Build 7.1 Schedule Update. Build 7.1 Limited Climb Via SID Compliance:. Susan S. . Ellenberg. , Ph.D.. University of Pennsylvania. SCT/ICTMC Joint Meeting. Liverpool, UK. May 8, 2017. CLINICAL TRIALS TIMELINE. 1948: First randomized clinical trials of modern era. 1962: Amendments to U.S. Food, Drug and Cosmetic Act requiring demonstration of efficacy as well as safety. IMPLEMENTATION OF . THE . FCTC PROTOCOL. ELIZABETH ALLEN . ITIC – JULY 2014. The . Protocol is a legally binding . instrument; once in force, . it will have significant implications . for . Customs enforcement . P. . Banerjee, . S. . Niddodi. , . H. . Lee, . A. . Srivastava. . and D. . Bakken. The School of Electrical Engineering and Computer Science. Washington State University. Patrick . Panciatici. RTE France. Back to the future? . Jeremy Grimshaw. Senior Scientist and . professor . Canada . Research Chair in Health Knowledge Transfer and Uptake. @. GrimshawJeremy. jgrimshaw@ohri.ca. 9. TH. MAY 2017. Foundational paper. HIV Cure Research Training Curriculum. Regulatory Issues Module by:. Damon Deming, Ph.D.. FDA Division of Antiviral Products. Nov 2014 . The HIV CURE training curriculum is a collaborative project aimed at making HIV cure research science accessible to the community and the HIV research field. . and Options for Regulators. Institute of Medicine Workshop . International Regulatory Harmonization Amid Globalization of Biomedical Research and Medical Product Development. Washington DC, February 13-14, 2013. (i.e. no one has seen or approved this). Draft 07/01/13. Coordination. This is the point at which we need to truly start integrating the work products of the subgroups. .. We need to look at the safety issues and assess whether they are addressed. CLINICAL TRIALS IN THE TWENTY-FIRST CENTURY: ONGOING CHALLENGES AND EMERGING ISSUES Susan S. Ellenberg , Ph.D. University of Pennsylvania SCT/ICTMC Joint Meeting Liverpool, UK May 8, 2017 CLINICAL TRIALS TIMELINE Susan S. . Ellenberg. , Ph.D.. University of Pennsylvania. SCT/ICTMC Joint Meeting. Liverpool, UK. May 8, 2017. CLINICAL TRIALS TIMELINE. 1948: First randomized clinical trials of modern era. 1962: Amendments to U.S. Food, Drug and Cosmetic Act requiring demonstration of efficacy as well as safety. History, Current Regulations , and Future Considerations by Kalindi Naik Project Submitted to the School of Health Sciences Eastern Michigan University in partial fulfillment of the requirements for of. human . challenge trials. Nele Berthels. FAMHP Vaccine Symposium. , . BRUSSELS, . 9 September 2017. Disclaimer. This presentation . reflects . my . personal point of . view, . and . not necessarily the . Inês Reis – Statistical assessor MHRA. PSI Career Young Statistician Webinar Session – 9 June 2020. Disclaimer. The views expressed in this presentation are my own and should not be understood or quoted as being made on behalf of the Medicines and Healthcare products Regulatory Agency (MHRA) or any other entity..

Download Document

Here is the link to download the presentation.
"Decentralized Trials: Regulatory and Implementation Issues"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.